William Blair Maintains Sell Rating on Ginkgo Bioworks Holdings

Ginkgo Bioworks Holdings (DNA) received a Sell rating from William Blair analyst Matt Larew, who maintains an average return of -8.1% and a 38.33% success rate on recommended stocks. The current analyst consensus is a Moderate Sell with an average price target of $10.00. DNA's market cap is $817.1M and has a P/E ratio of -1.50.

Ginkgo Bioworks Holdings Inc (DNA) reported a quarterly adjusted loss of $1.10 per share for the period ending June 30, 2025, according to a Reuters news article [2]. This loss is higher than the same quarter last year when the company reported an EPS of $-2.80. The mean expectation of three analysts for the quarter was for a loss of $1.57 per share, with Wall Street's median 12-month price target standing at $8.00, about 68.3% below its last closing price of $13.46 [2].

Revenue for the quarter fell by 11.7% to $49.60 million from a year ago, compared to analysts' expectations of $41.61 million. The company reported a quarterly loss of $60.3 million. Despite the financial setback, shares of Ginkgo Bioworks Holdings Inc have seen a significant increase, rising by 24.1% this quarter and gaining 42.2% so far this year [2].

The current analyst consensus is a Moderate Sell with an average price target of $10.00. William Blair analyst Matt Larew recently issued a Sell rating for the company, citing an average return of -8.1% and a 38.33% success rate on recommended stocks [1]. The company's market cap is $817.1M with a P/E ratio of -1.50 [1].

In the last three months, the mean earnings estimate of analysts had risen by about 5.2%, with no earnings estimate revisions in the last 30 days. The current average analyst rating on the shares is "sell," with a breakdown of recommendations including 1 "strong buy" or "buy," no "hold," and 3 "sell" or "strong sell" [2].

References:
[1] https://www.tradingview.com/news/reuters.com,2025:newsml_L8N3TX3Q8:0-ginkgo-bioworks-holdings-inc-expected-to-post-a-loss-of-1-57-a-share-earnings-preview/
[2] https://www.tradingview.com/news/reuters.com,2025:newsml_L8N3U00S8:0-ginkgo-bioworks-holdings-inc-reports-results-for-the-quarter-ended-june-30-earnings-summary/